about
Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature reviewContribution of acidic extracellular microenvironment of cancer-colonized bone to bone painBiology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Acidic microenvironment and bone pain in cancer-colonized boneTapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease.The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.Immunological dysregulation in multiple myeloma microenvironment.Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.Emerging treatment approaches for myeloma-related bone disease.Surgery for plasma cell neoplasia patients with spinal instability or neurological impairment caused by spinal lesions as the first clinical manifestation.Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma.Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey.Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation.Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.The comprehensive clinical management of multiple myeloma and related-plasma cell disorders.The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.Pathogenesis of bone disease in multiple myeloma: from bench to bedside.Mechanisms of bone destruction in multiple myeloma.Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma.Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue.Percutaneous Balloon Kyphoplasty Vertebral Augmentation for Compression Fracture Due to Vertebral Metastasis: A 12-Month Retrospective Clinical Study in 72 Patients.Multimodal Treatment of Bone Metastasis-A Surgical Perspective
P2860
Q26860175-09D97F16-D054-47E6-9839-12B6E4B1CE65Q28085753-16FA31A8-3E23-486A-8972-82CC55175F57Q34366449-9B9ABD8D-E6C5-44D3-8813-EA7B9896D916Q35575632-AA80C958-0AC5-4429-9B21-52CDAB56AF47Q35605900-7FDBAF08-BACE-4877-9F6F-93C5C0FE3726Q37644252-6BCABFCD-1304-411A-9E48-9779D33ADFBCQ37671439-93C79D3F-9A8C-4C1A-B1CD-22340118D860Q38228353-505A6B5C-C2FA-4847-96E2-AD416FBE2F96Q38367654-4592E34F-1236-4068-81B7-245B1751565CQ39090721-46E0D144-91F2-4937-8841-6596AC62D3E3Q39196923-12C3FE1D-98DF-47E3-B09F-798D55962027Q39530606-724210F8-9E8B-4EAB-B494-D2451BF4A9B1Q39595554-6A228881-F7F6-4187-B616-AB241088A974Q41053000-F188ABDF-24F9-4243-B6F3-4243DF7CB93AQ41162635-C53A4FC1-4F0E-4F40-9B52-1C25420876D0Q41729858-386E9B74-1412-4F03-AE43-1905F4003C82Q42292367-32BE5CFF-1AF5-476C-B5B2-A96262D1D644Q47141750-1FD05C8A-A55C-4618-B480-753D6EA4ECB1Q47608445-16118BC5-CF60-44D6-A612-78A26F857204Q47619227-2390672F-8521-461E-A041-A5ABD36E92E6Q47734632-B651CF2A-9EE9-4C99-B6D3-EB3F5206F38CQ47756922-BAE9492D-5068-42F3-84BC-7126F3315D75Q50318733-05750A9A-9249-452B-8DA1-5D7911D21F0FQ52670810-CBE16A33-AA1F-4AEC-8B56-AB09B8CCCF08Q55311492-98C3077D-21B2-4011-9A15-CEA547319872Q55406280-44734504-DE1B-4CF5-88EF-CB44B9A94A2CQ57652753-5BD77BF9-79CC-4344-B25D-73313C60B8BD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of bone disease in multiple myeloma.
@en
type
label
Management of bone disease in multiple myeloma.
@en
prefLabel
Management of bone disease in multiple myeloma.
@en
P2093
P2860
P1476
Management of bone disease in multiple myeloma.
@en
P2093
Evangelos Terpos
G David Roodman
James Berenson
Noopur Raje
P2860
P304
P356
10.1586/17474086.2013.874943
P577
2014-01-16T00:00:00Z